L’anticorps anti-CYFIP2 Polyclonal Lapin est utilisé pour la détection de CYFIP2 dans des échantillons de Humain, Souris et Rat. Il a été validé pour WB et ELISA.
CYFIP2
Reactivité: Humain, Souris, Rat
WB, ELISA
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:10000-20000
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Date de péremption
12 months
Antigène
CYFIP2
(Cytoplasmic FMR1 Interacting Protein 2 (CYFIP2))
Autre désignation
CYFIP2
Sujet
Cytoplasmic FMR1-interacting protein 2, p53-inducible protein 121CYFIP2 belongs to the CYFIP family and is involved in T-cell adhesion and p53-dependent induction of apoptosis. CYFIP2 mRNA is ubiquitously expressed and particularly abundant in the central nervous system. Recently, CYFIP2 was regarded as one of the ALS potential biomarkes in non-neural tissues from amyotrophic lateral sclerosis (ALS) patients that may have direct diagnostic and therapeutic implications to the disease.